Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BMP-7 mRNA delivered by Fibrin-CaP scaffolds activates osteogenic programs in vivo as evidenced by transcriptomic and proteomic analyses.

Bioactive materials·2026
Same author

mRNA therapy improves the composition and motility in CCDC40-deficient cilia in vitro and in vivo.

American journal of respiratory cell and molecular biology·2026
Same author

Inside the cell: Approaches to evaluating mRNA internalization and trafficking.

Methods (San Diego, Calif.)·2025
Same author

Implementing BMP-7 Chemically Modified RNA for Bone Regeneration with 3D Printable Hyaluronic Acid-Collagen Granular Gels.

Advanced healthcare materials·2025
Same author

Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.

Emerging microbes & infections·2025
Same author

Improved tendon repair with optimized chemically modified mRNAs: Combined delivery of Pdgf-BB and IL-1Ra using injectable nanoparticles.

Acta biomaterialia·2025

Related Experiment Video

Updated: Mar 15, 2026

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

8.1K

Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration.

Zohreh Sadat Badieyan1, Taras Berezhanskyy2, Maximilian Utzinger3

  • 1Institute of Molecular Immunology - Experimental Oncology, Technische Universität München, Munich, Germany.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|September 3, 2016
PubMed
Summary

Chemically modified messenger RNAs (cmRNAs) in collagen sponges, called transcript activated matrices (TAMs), offer sustained protein delivery. This novel approach shows promise for bone regeneration and regenerative medicine applications.

Keywords:
Bone regenerationChemically modified mRNA (cmRNA)Human bone morphogenetic protein 2 (hBMP-2)Sustained deliveryTranscript therapyTranscript-activated matrix (TAM)

More Related Videos

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.1K
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
07:53

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

18.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

8.1K
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.1K
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
07:53

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

18.6K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Materials Science

Background:

  • Chemically modified messenger RNAs (cmRNAs) offer a promising alternative to gene therapies but face limitations in stability and transient translation.
  • Current applications of cmRNAs are hindered by their short in vivo lifespan compared to DNA-based therapies.

Purpose of the Study:

  • To develop a novel delivery system for sustained release of cmRNAs.
  • To evaluate the efficacy of transcript activated matrices (TAMs) for protein delivery and bone regeneration.

Main Methods:

  • Vacuum-dried cmRNA-loaded collagen sponges (TAMs) were created for sustained cmRNA delivery.
  • In vitro studies assessed transfection efficiency, protein production, and toxicity.
  • In vivo studies utilized human BMP-2-encoding TAMs to evaluate bone regeneration in a rat femoral defect model.

Main Results:

  • TAMs demonstrated sustained protein production for up to 11 days post-transfection.
  • The technology achieved nearly 100% transfection efficiency with low in vitro toxicity.
  • Human BMP-2-encoding TAMs successfully induced osteogenic differentiation and bone regeneration in vivo.
  • TAMs exhibited stability for at least 6 months at room temperature.

Conclusions:

  • Transcript activated matrices (TAMs) represent a stable and effective depot system for sustained cmRNA delivery.
  • TAMs show significant potential for applications in bone regeneration and broader regenerative medicine.
  • This technology overcomes key limitations of traditional cmRNA therapies, enhancing their therapeutic utility.